MSB 1.36% $1.12 mesoblast limited

The practise of diminishing a cell therapy companies prospects...

  1. 6,119 Posts.
    lightbulb Created with Sketch. 1053
    The practise of diminishing a cell therapy companies prospects that has multiple late stage products in a favourable regulatory environment will become increasingly harder @dingle

    Let the SP do the talking and lets increase the exposure of the cell therapy science and its place in medicine.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.12
Change
0.015(1.36%)
Mkt cap ! $1.278B
Open High Low Value Volume
$1.13 $1.16 $1.10 $7.169M 6.411M

Buyers (Bids)

No. Vol. Price($)
4 7296 $1.12
 

Sellers (Offers)

Price($) Vol. No.
$1.12 43068 1
View Market Depth
Last trade - 16.10pm 08/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.